Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
- To evaluate the efficacy of treatment with SOF/GS-5816 for 12 weeks in subjects with chronic HCV infection as measured by the proportion of subjects with SVR12 - To evaluate the safety and tolerability of treatment with SOF/GS-5816 for 12 weeks
Inclusion criteria
- Chronic hepatitis C virus infection